Evidence map›Paper›PMID 35408790›Full record

ArticleInternational journal of molecular sciences2022

Expression of the Chemokine Receptor CCR1 in Burkitt Lymphoma Cell Lines Is Linked to the CD10-Negative Cell Phenotype and Co-Expression of the EBV Latent Genes EBNA2, LMP1, and LMP2.

Laura Zvejniece, Svetlana Kozireva, Zanna Rudevica, Ainars Leonciks, Barbro Ehlin-Henriksson, Elena Kashuba, Irina Kholodnyuk

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Increased Frequency of the Chemokine Receptor CCR2 on Circulating CD19+CD5+ Lymphocytes in Therapy-Naïve CLL Patients With the Detectable EBV DNA and High-Avidity Antibodies Against the EBV Capsid Antigen.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2026
    Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Laura ZvejnieceInstitute of Microbiology and Virology, Riga Stradins University, 5 Ratsupites Street, 1067 Riga, Latvia.
Svetlana KozirevaInstitute of Microbiology and Virology, Riga Stradins University, 5 Ratsupites Street, 1067 Riga, Latvia.
Zanna RudevicaLatvian Biomedical Research and Study Centre, 1 Ratsupites Street k-1, 1067 Riga, Latvia.
Ainars LeonciksLatvian Biomedical Research and Study Centre, 1 Ratsupites Street k-1, 1067 Riga, Latvia.
Barbro Ehlin-HenrikssonDepartment of Microbiology, Tumor and Cell Biology, Biomedicum, Karolinska Institute, SE-171 65 Stockholm, Sweden.
Elena KashubaDepartment of Microbiology, Tumor and Cell Biology, Biomedicum, Karolinska Institute, SE-171 65 Stockholm, Sweden.ORCID 0000-0001-7001-4035
Irina KholodnyukInstitute of Microbiology and Virology, Riga Stradins University, 5 Ratsupites Street, 1067 Riga, Latvia.ORCID 0000-0002-7208-4499
Riga Stradiņš University · LVLatvian Biomedical Research and Study Centre · LVKarolinska Institutet · SENational Academy of Sciences of Ukraine · UA

Funding

Latvian Council of Science lzp-2018/1-0156
6 · The paper itself

Abstract

Chemokines and their receptors regulate the migration of immune cells and the dissemination of cancer cells. CCR1, CCR2, CCR3, and CCR5 all belong to a single protein homology cluster and respond to the same inflammatory chemokines. We previously reported that CCR1 and CCR2B are induced upon Epstein-Barr virus (EBV) infection of B cells in vitro. EBV is present in almost all cases of endemic Burkitt lymphoma (BL); however, the contribution of EBV in the pathogenesis of the disease is not fully understood. Here, we analyzed the relation of the expression of

Indexed as

Burkitt LymphomaEpstein-Barr Virus InfectionsReceptors, CCR1Cell LineHerpesvirus 4, HumanHumansPhenotypeViral Matrix ProteinsViral ProteinsCCR1 protein, humanEBV-associated membrane antigen, Epstein-Barr virusReceptors, CCR1Viral Matrix ProteinsViral ProteinsBurkitt lymphoma cell linesCCR1CCR2CCR3CCR5EBV

Identifiers

PMID35408790
PMCPMC8998437
OpenAlexW4220905995

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.